Stark David Matthew
SEC CIK 1722360 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP CLO | 52.4K | — | $2.13M | 11 | 2022-02-09 | 2023-03-06 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
Stark David Matthew made no open-market trades at TEVA in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-08 | 2023-03-06+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | S - Sale | $9.55 | -66.0K | 52.4K | -56% | -$630.3K |
| DM | 2023-03-07 | 2023-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | M - OptEx | — | +66.0K | 68.9K | +2,218% | — |
| DM | 2023-03-02 | 2023-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | M - OptEx | — | +63.4K | 47.9K | New | — |
| DM | 2023-03-02 | 2023-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | S - Sale+OE | $9.89 | -63.4K | 2,974 | -96% | -$626.9K |
| 2022-07-29 | 2022-07-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | S - Sale | $9.04 | -58.2K | 2,974 | -95% | -$525.8K | |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | M - OptEx | — | +72.1K | 59.3K | New | — |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | S - Sale+OE | $7.45 | -32.3K | 42.3K | -43% | -$240.7K |
| D | 2022-03-02 | 2022-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | M - OptEx | — | +18.4K | 27.8K | +196% | — |
| D | 2022-03-02 | 2022-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | S - Sale+OE | $8.14 | -6,452 | 21.4K | -23% | -$52.5K |
| D | 2022-02-10 | 2022-02-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | S - Sale+OE | $9.06 | -6,110 | 9,402 | -39% | -$55.4K |
| D | 2022-02-10 | 2022-02-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Stark David Matthew | EVP CLO | M - OptEx | — | +12.5K | 15.5K | +422% | — |
Purchase Sale Sale after option exercise All abbreviations